The 20 Best Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Doctors Near Me in Ann Arbor, MI

Kara J. Wyant, MD, is a clinical lecturer in the Department of Neurology. She received her bachelor’s degrees in mathematics and music from Ohio Northern University, and medical degree from the University of Toledo College of Medicine. Dr. Wyant completed her neurology residency training at the University of Pittsburgh Medical Center, where she served as chief resident from 2015-2016. She is currently pursuing a fellowship in movement disorders at the University of Michigan focusing on the medical and surgical management of patients with Parkinson disease and parkinsonism. Dr. Wyant also serves on the neurohospitalist service at University Hospital, and participates in teleneurology consults for MidMichigan Health. Dr. (md) is rated as a Distinguished provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Drug Induced Dyskinesia, Parkinson's Disease, Movement Disorders, Dopa-Responsive Dystonia, and Deep Brain Stimulation. Dr. (md) is board certified in Neurology.

Dr. Praveen Dayalu is an Associate Professor and the Thomas H. and Susan C. Brown Early Career Professor of Neurology at the University of Michigan. He graduated from medical school at Case Western Reserve University in Cleveland, in 2002, and then completed neurology residency and movement disorders fellowship at Michigan, in 2006. His main focus is clinical management of movement disorders, especially Parkinson disease. His research interests are in Huntington disease and Multiple System Atrophy. He is the Director of the Movement Disorders Fellowship and trains fellows, residents, and medical students. Dr. Dayalu is rated as a Distinguished provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Huntington Disease, Movement Disorders, Drug Induced Dyskinesia, and Parkinson's Disease. Dr. Dayalu is board certified in Neurology.

Wayne Cornblath is a Neurologist and an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Cornblath is rated as an Advanced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Myasthenia Gravis, Increased Intracranial Pressure, and Benign Essential Blepharospasm.

Mala Young is a Physiatrist practicing medicine in Ann Arbor, Michigan. Dr. Young is rated as an Advanced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Drug Induced Dyskinesia, Meige Syndrome, Dopa-Responsive Dystonia, and Familial Paroxysmal Nonkinesigenic Dyskinesia.

Martha Carlson is a Pediatrics specialist and a Pediatric Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Carlson is rated as an Experienced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. She is also highly rated in 41 other conditions, according to our data. Her clinical expertise encompasses Autism Spectrum Disorder, Seizures, Stereotypic Movement Disorder, and Spasmus Nutans.

Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Experienced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).

Kelvin L. Chou, M.D. is a Clinical Professor in the Departments of Neurology and Neurosurgery at Michigan Medicine and was the inaugural Thomas H. and Susan C. Brown Early Career Professor in Neurology. Dr. Chou has been named to the Best Doctors of America list since 2011 and sees all patients with movement disorders (i.e. Parkinson’s disease, tremors, dystonia, Huntington disease), though he has a particular interest in Parkinson’s disease (PD) and deep brain stimulation (DBS). Dr. Chou serves as Co-Director of the STIM (Surgical Therapies Improving Movement) Program and his research focus is on improving the ability to treat movement disorders patients through DBS. He is also an experienced clinical trialist, conducting numerous clinical trials on new therapies for PD, essential tremor and Huntington disease. He directs the Neurology Clinical Trials Organization (NeCTO) and is Lead Medical Director of the Neuroscience and Sensory Clinical Trials Support Unit (CTSU) at Michigan Medicine. He has published over 100 peer-reviewed journal articles, review articles or book chapters on PD and related movement disorders. A strong patient advocate, Dr. Chou is the Education and Outreach Core Director for the U-M Udall Center of Excellence for PD Research and serves on the Professional Advisory Board of the Michigan Parkinson Foundation and the Medical Advisory Board of the International Essential Tremor Foundation (IETF). He has also authored a book for patients and families called Deep Brain Stimulation: A New Life for People with Parkinson's, Dystonia and Essential Tremor. Dr. Chou is rated as an Experienced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Essential Tremor, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Chou is board certified in Neurology.

Amelia Heston is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Heston is rated as an Experienced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Parkinson's Disease, Movement Disorders, Chorea, Deep Brain Stimulation, and Thrombectomy. Dr. Heston is board certified in Neurology.

Roger L. Albin, M.D. (Residency 1986), is a professor of neurology, associate chair for research and co-director of the Movement Disorders Clinic in the Department of Neurology in the University of Michigan Medical School. In addition, he serves as chief of neuroscience research at the VA Ann Arbor Healthcare System Geriatric Research Education and Clinical Center.Dr. Albin joined the U-M faculty in 1988 as an instructor in the Department of Neurology. He was promoted to assistant professor in 1989; associate professor in 1994; and achieved his current rank of full professor in 2000.After completing his undergraduate degree at Oberlin College in Ohio, Dr. Albin earned his medical degree from the University of Pittsburgh School of Medicine in 1982, and completed his residency at the University of Michigan in 1986. He also completed a movement disorders fellowship in 1988 under Drs. Anne Young and John Penney.His clinical and research interests include the underlying neurobiologic causes of the clinical features of movement disorders, basal ganglia structure and function, Parkinson's disease, Tourette syndrome, dementias, dystonias and Huntington's disease. His laboratory is pursuing work on basic mechanisms of neurodegeneration in Huntington disease using mouse genetic models. Dr. Albin also has participated in neuroprotective clinical trials for both Huntington's disease and Parkinson's disease.The present focus of Dr. Albin's group is uncovering the basis for non-motor (sleep disorders, depression, dementia, autonomic dysfunction) problems in Parkinson's disease. He is very interested in applying positron emission tomography (PET) imaging methods to improve diagnosis of dementing disorders like Alzheimer's disease. The hope is that understanding how specific brain alterations cause specific clinical features will lead to improved treatments.Dr. Albin currently serves as a site investigator for the National Institutes of Health (NIH) Exploratory Trials in Parkinson disease (NET-PD) initiative. His work is supported by grants from the NIH, the Michael J. Fox Foundation and the High Q Foundation.A member of the American Academy of Neurology, the American Association for the Advancement of Science, the American Neurologic Association, and the Society for Neuroscience, Dr. Albin currently serves on the editorial boards of Experimental Neurology, Neurology and Neurobiology of Disease. Dr. Albin is rated as an Experienced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Huntington Disease, Dementia, and Deep Brain Stimulation. Dr. Albin is board certified in Neurology.

Dr. Sean Smith is the Medical Director of Michigan Medicine's Cancer Rehabilitation program, with a clinical emphasis on restoring function and reducing symptom burden in patients with a history of cancer. In addition to chairing the AAPM&R's Cancer Rehabilitation Physician Consortium and the multi-site research collaborative, the Cancer Rehabilitation Metrics Consortium, he serves on the editorial board of the Journal of Clinical Oncology, and is a Deputy Associate Editor for Supportive Care in Cancer. He has published numerous peer-reviewed manuscripts and has conducted educational seminars on cancer rehabilitation on three continents. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Foot Drop, Lymphedema, and Femoral Nerve Dysfunction. Dr. Smith is board certified in Physical Medicine & Rehab.

Maryam Berri MD, is a Clinical Assistant Professor in the Department of Physical Medicine and Rehabilitation at the University of Michigan Medical School.Clinical work includes concomitant traumatic brain and spinal cord injury, myelomeningocele, cerebral palsy, and neurogenic bowel disease treatment. She is pursuing research in lactational outcomes and management for those with neurological disease. She has a strong interest in medical education as well as education and optimization in practice management for faculty. She serves as the revenue physician lead for the department. She is an active in the rehabilitation Standards Committee with the American Spinal Injury Association.Dr. Berri received her BS degree from the University of Michigan in 2009, and then in 2013, she graduated from the American University of the Caribbean in Pembroke Pines, FL. She then completed her residency in Physical Medicine and Rehabilitation at Wayne State University followed by subspecialty fellowship in Spinal Cord Injury at the University of Michigan. Dr. Berri is rated as an Experienced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Autonomic Dysreflexia, Brown-Sequard Syndrome, Spasticity, and Neurogenic Bowel. Dr. Berri is board certified in Physical Medicine & Rehab, Spinal Cord Injury Medicine, and Brain Injury Medicine.

Dr. Chiodo is co-director for U-M SCIMS and has been the clinical director of Spinal Cord Injury Medicine at the University of Michigan since 2002. He has worked on the U-M SCIMS research projects, Wellness in SCI and Predictors of Health, and Quality of Life in Persons with Ventilator Assistance after SCI. He has published several manuscripts on pain management, wellness in SCI, and is preparing several manuscripts on ventilator weaning after SCI. He has served as a co-investigator for two clinical trials of Fampridine’s efficacy after SCI: as treatments for spasticity and for restrictive lung disease.Dr. Chiodo is the primary attending physician for SCI services in the UMHS Adult Rehabilitation Unit, coordinating all clinical services. Dr. Chiodo is rated as an Experienced provider by MediFind in the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Spasticity, Autonomic Dysreflexia, Paraplegia, and Spinal Stenosis. Dr. Chiodo is board certified in Pain Medicine, Physical Medicine & Rehab, Spinal Cord Injury Medicine, and Electrodiagnostic Medicine.